Optical coherence tomography (OCT) is a new imaging
Basal cell carcinoma (BCC) is the most prevalent skin cancer in the light-skinned population and is a frequent problem in daily dermatological practice (1, 2). Although surgical treatment is used mainly for nodular and deeper variants of BCC, especially located on the face, non-invasive treatment is increasingly used for patients with BCC who have superficial lesions, making the application of non-invasive diagnostic technologies highly relevant (3-5). Various diagnostic tools are available, including dermoscopy, fluorescence imaging, confocal microscopy, high-frequency ultrasound (HFUS), and optical coherence tomography (OCT) (6). Whereas the first ones of these tools can be used to improve clinical diagnostic accuracy, HFUS and OCT are most useful in the estimation of tumour size, which is used in planning surgical approaches as well as choosing thin lesions suitable for non-surgical management. For decades, HFUS has been a well-established technique for determining preoperative thickness of melanocytic and non-melanocytic skin tumours, and is used frequently, especially in European countries (7) (8) (9) (10) (11) (12) . For dermatological purposes, high-frequency scanners of 20-50 MHz are used to evaluate skin morphology. The penetration of a 20 MHz ultrasound transducer is approximately 3.8 mm, with an axial resolution of 39 µm and a lateral resolution of 210 µm, which does not approach the resolution of a light microscope. However, HFUS is helpful in detecting and describing the morphological and volumetric appearance of skin tumours in vivo. OCT, on the other hand, is a novel optical imaging technique that offers real-time imaging within micrometre resolution (13-16). It works in an analogous fashion to ultrasound imaging, except that it uses light rather than sound waves. Although OCT was only recently introduced in skin cancer imaging, first studies on melanoma as well as of non-melanoma skin cancer (NMSC) indicate promising results (17) (18) (19) (20) . Few studies have compared OCT, HFUS and histopathological tumour thickness measurements for BCC (21).
The aim of the current study was to compare the accuracy of OCT and HFUS measurements in vivo, and to correlate the results with the histopathological tumour thickness measured in patients with the clinical diagnosis of a BCC. In addition, morphological aspects of BCCs studied with OCT were assessed.
MATERIALS AND METHODS

Patients
From July to August 2010, 10 patients with the clinical presumptive diagnosis of a BCC were scanned by OCT and HFUS. The study population consists of 1 woman and 9 men with a mean age (± standard deviation (SD)) of 73.8 ± 6.03 years (age range 62-80 years). After scanning of the tumours, excisions were performed, followed by histopathological examinations. The study followed the principles outlined in the Declaration of Helsinki. All patients gave written informed consent.
High-frequency ultrasound
A commercially available real-time high-resolution 20 MHz HFUS probe (taberna pro medicum, Lueneburg, Germany) was used with an axial resolution of 72 μm and maximum measurable depth of 8-10 mm. As a coupling agent water was needed between the skin surface and the probe. The linear probe was applied with minimal pressure perpendicular to the skin surface and moved over the skin to visualize the entire lesion. We compared the internal echogenicity of all lesions using standard ultrasound terminologies and criteria such as isoechoic, hypoechoic or hyperechoic compared with surrounding tissue, and additionally characterized the pattern of internal echoes as homogeneous or heterogeneous. In HFUS, non-melanocytic skin tumours generally appear as homogenous hypoechoic structures compared with the surrounding hyperechoic dermis. It is not possible to differentiate between skin tumours by means of HFUS. Lesion margins and the demarcation from normal skin were documented. The thickness was measured independently by 2 investigators (TH and MHSW) on a vertical axis perpendicular to the surface (from the middle of the so-called hyperechoic "entrance echo" to the deepest point of the lesion) using an electronic calliper.
Optical coherence tomography
OCT is a non-invasive, depth-resolved, non-destructive optical imaging method, that measures reflection of infrared radiation from the skin. For the current study, a Swept-Source-OCTSystem (OCS1300SS, Thorlabs, Dachau/Munich) was used, based on frequency-domain technology. The laser radiation is focused on the surface of the tissue with an objective. The different structures of the tissue reflect different percentages of the radiation. The back-reflected radiation of all layers is collected by the objective and is redirected to the beam splitter, where the signal is superimposed with the signal of the reference arm. The combined signal is measured by a single-photodetector as a function of time. The swept laser source of the system used in this study has a centre wavelength of 1,325 nm, with a spectral bandwidth of 100 nm and a sweeping frequency of 16 kHz. The parameters of the system yield to a maximum theoretical imaging depth of 3 mm and an axial resolution of 12 µm in air. The real imaging depth in tissue is, due to scattering effects, lower than in air and varies around approximately 1 mm according to body site and type of lesion. The lateral resolution is 15 µm. A charge-coupled device (CCD)-camera provides a surface image of the measured region. The system has an aiming laser (660 nm) showing the scanning trace of the swept laser on the surface of the skin in order to improve the user's orientation. For all measurements acquired in this study an image size of 6 mm lateral (1024 pixels) and 2.26 mm axial (3 mm in air, 512 pixels) was used. Every lesion was measured by setting the handheld imaging probe onto the lesion. Then its position was corrected by monitoring the trace of the aiming laser and the real-time OCT image of the lesion until a good cross-sectional image of the lesion was displayed on the screen. After acquiring the OCT image the thickness of the lesion was measured independently by 2 investigators (TH and MHSW) using the software provided by the manufacturer of the OCT system. One horizontal measurement line was set to the upper margin of the lesion, the other was set to the lower margin. The software of the system provides the calculated distance between the 2 measurement lines. For getting correct measurements the refraction index was set to 1.33, which is a typical value for tissue.
Excision and histological examination
All skin tumours were removed with 3-5 mm margins, resulting in complete excisions, and processed for histopathological examination following the above-mentioned imaging procedures. Specimens were fixed in formaldehyde and stained routinely with haematoxylin and eosin. Histopathological diagnoses were made by an experienced dermatopathologist (LE) and the vertical thickness of the BCCs was measured using a micrometer on histology slides, with the vertical axis perpendicular to the skin surface. The dermatopathologist was blinded to the results of HFUS and OCT imaging.
Statistical analysis
The differences in mean tumour thickness measured by OCT and HFUS in reference to measurement by histopathology were illustrated by Bland-Altman plots. The correlation of tumour thickness in OCT, HFUS and histopathology was assessed by Pearson's correlation coefficient. Data were calculated with SPSS software (SPSS 17.0 for Windows; SPSS Inc., Chicago, IL, USA).
RESULTS
Features of tumours
Ten BCCs from 10 patients were identified for study inclusion, processed and excised as above. Two lesions were located on the trunk, 5 were located on the head, and 3 on the limbs. Histopathological examination Table I .
High-frequency ultrasound
In HFUS, all BCCs presented solid homogenous hypoechoic lesions beneath a strong hyperechoic entrance echo. In many cases, the hypoechoic lesions could be distinguished well by a sharp border between the hypoechoic lesion and the surrounding hyperechoic dermis. Histological subclassification of BCCs could not be achieved with HFUS ( Figs 1A) . Measurements of vertical tumour thickness (represented by white double arrows in Figs 1A ) could be performed in all cases ( Table I ). The mean tumour thickness of the 10 BCCs estimated by HFUS was 1.03 mm, compared with 0.82 measured by histopathology (Table II) .
Optical coherence tomography
In OCT, BCCs presented as well-defined grey or dark areas with a more or less homogenous signal distribution. In some cases a white peripheral surrounding could be observed illustrating the tumour stroma. In addition, destruction of the normal architecture, resulting in break-up of the layering was also seen. Representative OCT images of 3 BCCs are shown in Figs 1B, demonstrating less-defined dermoepidermal borders and a disarrayed architecture. Vertical tumour measurements are summarized in Table I . The mean tumour thickness of all 10 BCCs measured by OCT was 0.65 mm ± 0.29 mm), which is very close to the mean tumour thickness of 0.82 ± 0.46 mm) finally measured by histopathology (Table II) .
Comparison of the measurements
Taking the histopathological tumour thickness as "gold standard", OCT revealed more exact vertical tumour thickness measurements of BCCs compared with 20 MHz ultrasound (see the mean as well as the median values listed in Table II ). Tumour thickness values measured by OCT did not differ significantly from those measured by histopathology (median difference 0.12 mm). In contrast, there was a clearly higher dif- ference between HFUS and histopathology tumour thickness measurement (median difference 0.30 mm) with a tendency to overestimation using HFUS. The opposite was true for OCT imaging, which tended to underestimate tumour thickness. For comparison of tumour thickness, Pearson's correlation coefficients were calculated (Table III) 
DISCUSSION
Several studies focusing on non-invasive diagnosis and estimation of tumour margins in BCC by ultrasound have been published during the last decades (7, 8, (22) (23) (24) (25) (26) . In the preoperative setting, especially, tumour thickness estimation had been shown to be useful (7, 22) . In a comprehensive study, Desai et al. investigated 50 superficial and nodular BCCs at various locations using a 20 MHz ultrasound device (22). Clinical and ultrasonic tumour thickness measurements correlated well for width, depth and length of the investigated tumours. Forty-five out of 50 tumours had been assessed with clear margins by HFUS (22). Another study including 25 patients with 27 skin lesions suspicious for facial BCCs, revealed positive findings for the pre-surgical HFUS employing a special compact linear 15 MHz probe, designed for difficult anatomical areas such as the nose (23). The authors reported that HFUS enabled the additional detection of 2 subclinical satellite lesions, resulting in the correct estimation of tumour margins in 29 facial BCCs, which could be removed with tumour-free borders at the first surgery (23). A more critical view of HFUS was presented in a comprehensive study by Jambusaria-Pahalajani et al. (8), who enrolled 100 patients with NMSC (BCCs as well as SCCs) for preoperative HFUS before Mohs micrographic surgery. A sensitivity of 32%, a specificity of 88% and a positive predictive value of 47% was reported. The authors pointed out that tumours with subtle areas of extension, such as small foci of dermal invasion, are an especially serious problem for HFUS diagnostics.
OCT was recently introduced as a new imaging technique that might overcome the disadvantages of HFUS in tumour diagnostics (27). Olmedo and his group compared tumour thickness values of 20 BCCs measured by OCT with values raised by histopathology, and found an excellent correlation of tissue thickness up to a depth of approximately 1 mm (28). In contrast to HFUS, OCT offers the possibility to describe tumour morphology and to give hints about tumour typical architecture, although cellular morphology cannot be identified (17, (28) (29) (30) . In the present study, it was possible to identify several morphological characteristics, such as break-up of layering and dark roundish tumour areas surrounded by a white core, corresponding to the histopathology of BCC islands with surrounding stroma Mogensen et al. (21) , who investigated the accuracy of OCT and HFUS for in vivo tumour thickness measurements of actinic keratoses and BCCs and compared their data with histo pathological findings. According to the OCT device used, the vertical thickness of the lesions was limited to a depth of 2 mm. As in our study, OCT was revealed to be superior to HFUS regarding the accuracy of tumour thickness measurement. The authors felt that the better results obtained by OCT were explained by the better resolution of OCT and the better contrast of BCCs and actinic keratoses from back-scattered infrared radiation, compared with the contrast provided by the acoustic characteristics of the tissue (21). Just as Mogensen et al. (21) and Olmedo et al. (28) found, the advantage of OCT over HFUS was most pronounced for smaller BCCs (< 1 mm tumour thickness) in our patient collective. Unlike the previous studies, we did not observe any overestimation of BCCs by OCT. This may be explained in part by the OCT device used (which is not yet available for commercial use) and by the inclusion of all skin lesions clinically suspicious for BCC without exclusion of tumours exceeding the OCT limit of 1 mm. Known problems from HFUS, such as the additional measurment of a peripheral inflammation beneath the tumours could not be observed for OCT measurements in the present investigation.
Based on our own data on a small number of patients, we conclude that OCT might be a suitable tool for the non-invasive measurement of tumour thickness in BCCs, which is superior to HFUS, especially in thin tumours. It might also have the potential for the preoperative evaluation of other thin NMSC (tumour thickness < 1 mm). However, further studies are needed, including larger study populations and considering potential influencing factors, such as skin hydration and pigmentation to finally assess the value of OCT for in vivo imaging. Another limitation of our study besides the small study population size might be that the exact points of measurement by OCT and HFUS might not be congruent with the areas measured by histopathology. Here, further developments of OCT devices might help to enable the physician using aiming laser beams for exact marking of special areas within skin lesions in the future. Another factor that might influence the measurement of skin lesion thickness is tissue shrinkage after formalin fixation and embedding in paraffin. Salmhofer et al. investigated the influence of this phenomenon on melanocytic as well as epithelial lesions, comparing HFUS and histopathological tumour thickness measure ments. They showed that the mean histological tumour thickness was only slightly lower than the mean thickness measured by HFUS, which they felt was due to primary expansion of tissue after excision, followed by shrinkage after formalin fixation (32). Besides the measurements of tumour thickness, morphological aspects will be an important issue in the future (33). Concerning this point, the recently published, so-called, speckle reduction technique (SR-OCT) might be of interest (30). In an experimental setting, SR-OCT lead to improved images of BCC lesions due to repeated scanning, by altering the distance between the probe and the skin surface (34). Improved imaging of BCCs is of great clinical importance, not only for preoperative estimation of tumour thickness and margins, but also for selection of patients with superficial tumours suitable for other therapeutic approaches, such as photodynamic therapy or 5-fluorouracil treat ments (25, 26) .
